Providing commercial, marketing and business support to varied entities including three start-ups in the Republic of Georgia (ex-USSR), non-life science ventures, The Apjohn Group, Genemarkers, Western Michigan University Office of Technology Transfer (viral oncolytics) and diagnostic for cancer & contrast media.

General Partner within an accomplished team of experienced business and pharmaceutical executives that has demonstrated success in working with innovators to launch early stage life science companies.

An angel investor, financing privately held companies or ventures typically in an early stage of development.

• Developed the life cycle management of a Phase II Women’s Healthcare compound with a biotech startup in clinical trial.
• Directed the long-range market lifecycle plan, including KOL development, publications, market research, market segmentation and pricing to characterize the market for future development and commercialization.
• Directed the program and secured the nonproprietary name for the Company's lead oncology compound.

Led strategic and tactical marketing efforts to generate growth of vaccines and antibiotics to penetrate an animal health market segment, exceeding revenue targets by 31% through a well-articulated brand strategy.

Formulated comprehensive sales, marketing, and operational strategies to ensure a U.S. company footprint was established for eventual commercialization of upstream pipeline compounds.

Spearheaded efforts for marketing, pricing, market research and product management.
• Added marketing planning unit to grow sales for X-Ray, MRI, CT scan, ultrasound, and nuclear products. Improved annual profitability by 13%.
• Led development of flawless and targeted strategic action plans, growing revenue from $656MM to $735MM.

• Directed the launch of a newly licensed, fifth entry migraine product, penetrating a high-spend, extremely competitive $1.4B+ market, achieving first year sales forecast in excess of 30%.
• Directed and managed five alliances, launched products via co-marketing and in-licensed models.